One-third of the world’s population harbours the latent tuberculosis infection (LTBI) with a
lifetime risk of reactivation. Although, the treatment of LTBI relies significantly on the first-line
therapy, identification of novel drug targets and therapies are the emerging focus for researchers across
the globe. The current review provides an insight into the infection, diagnostic methods and
epigrammatic explanations of potential molecular targets of dormant phase bacilli. This study also
includes current preclinical and clinical aspects of tubercular infections and new approaches in antitubercular
drug discovery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.